Pcas: Release of the 2021 Universal Registration Document (URD)

RELEASE OF THE 2021UNIVERSAL REGISTRATION DOCUMENT (URD)Ecully ,April29 , 2022 The PCAS Universal Registration Document 2021, which includes the annual financial report, was filed with France's Financial Markets Authority, in ESEF format (European Single Electronic Format), on April 29, 2022, under number D.22-0386.This document contains: The 2021 annual financial reportThe Board of Directors' corporate governance report in accordance with Section L.225-37 of...

LONGJUMEAU, 29/04/2022 (informazione.it - comunicati stampa - industria)

RELEASE OF THE 20 2 1 UNIVERSAL REGISTRATION DOCUMENT (URD)

Ecully , April 29 , 202 2

The PCAS Universal Registration Document 2021, which includes the annual financial report, was filed with France's Financial Markets Authority, in ESEF format (European Single Electronic Format), on April 29, 2022, under number D.22-0386.

This document contains:

This document is now available:

ABOUT PCAS

PCAS specializes in the development and production of complex molecules for life sciences and innovative technologies. With about 12% of its net sales earmarked for R&D and a large international footprint, PCAS is the preferred industrial partner for market-leading major global groups. Boasting especially high standards, the company offers a growing range of proprietary products and solutions in leading-edge segments. PCAS generated net sales of €187.0 million in 2021 and employs nearly 1200 people in six countries.

To find out more about PCAS: www.pcas.com

Attachment